Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01812252
Title Chemotherapy in Treating Patients With Myelodysplastic Syndrome Before Donor Stem Cell Transplant
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Fred Hutchinson Cancer Research Center
Indications

bone marrow cancer

Therapies

Cytarabine + Idarubicin

Azacitidine + Decitabine

Age Groups: adult
Covered Countries USA


No variant requirements are available.